Xinyi Pharmaceutical

Xinyi Pharmaceutical, a core subsidiary of Shanghai Pharmaceuticals Holding, is one of China's oldest and most prestigious pharmaceutical enterprises, established in 1916. The company specializes in the research, development, and large-scale manufacturing of a wide array of chemical drugs, biological products, and micro-ecological preparations. Its extensive product portfolio spans critical therapeutic areas including cardiovascular health, gastroenterology, infectious diseases, and neuropsychiatry. Xinyi is particularly renowned for its market-leading probiotics and its commitment to high-quality generic medications that meet international regulatory standards. With multiple state-of-the-art manufacturing bases and a robust R&D infrastructure, the company plays a pivotal role in the Chinese healthcare landscape. Xinyi continues to expand its reach through strategic partnerships and a focus on both traditional formulations and modern drug delivery systems.